Repositorio Dspace

SEOM clinical guidelines for anaemia treatment in cancer patients (2020)

Mostrar el registro sencillo del ítem

dc.contributor.author Escobar-Álvarez, Y
dc.contributor.author de-las-Penas-Bataller, R
dc.contributor.author Pérez-Altozano, J
dc.contributor.author Ros-Martínez, S
dc.contributor.author Sabino-Álvarez, A
dc.contributor.author Blasco-Cordellat, A
dc.contributor.author Brozos-Vazquez, E
dc.contributor.author Corral-Jaime, J
dc.contributor.author García-Escobar, I
dc.contributor.author Beato-Zambrano, C
dc.date.accessioned 2025-11-18T09:26:17Z
dc.date.available 2025-11-18T09:26:17Z
dc.date.issued 2021-05
dc.identifier.citation Escobar Álvarez Y, De Las Peñas Bataller R, Perez Altozano J, Ros Martínez S, Sabino Álvarez A, Blasco Cordellat A, et al. SEOM clinical guidelines for anaemia treatment in cancer patients (2020). Clin Transl Oncol. mayo de 2021;23(5):931-9.
dc.identifier.issn 1699-048X
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/20703
dc.description.abstract Anaemia is defined by the presence of haemoglobin (Hb) levels-<-13 g/dL in men and 12 g/dL in women. Up to 39% of cancer patients present it at the time of diagnosis and up to 40% have iron deficiency. Anaemia causes fatigue, functional deterioration and a reduction in the quality of life; it has also been associated with a poorer response to anti-tumour treatment and lower survival. Basic diagnostic tests for anaemia are simple and should be a routine part of clinical practice. These guidelines review the available evidence on the use of different therapies for treating anaemia: erythropoiesis-stimulating agents, iron supplements, and transfusion of blood products.
dc.language.iso eng
dc.publisher Springer International Publishing Ag
dc.subject.mesh Algorithms
dc.subject.mesh Anemia/blood/complications/diagnosis/therapy
dc.subject.mesh Anemia, Iron-Deficiency/complications/diagnosis
dc.subject.mesh Diagnosis, Differential
dc.subject.mesh Dietary Supplements/adverse effects
dc.subject.mesh Erythrocyte Transfusion/adverse effects/methods
dc.subject.mesh Female
dc.subject.mesh Hematinics/adverse effects/therapeutic use
dc.subject.mesh Humans
dc.subject.mesh Iron/administration & dosage/adverse effects
dc.subject.mesh Male
dc.subject.mesh Medical Oncology
dc.subject.mesh Neoplasms/complications/mortality
dc.subject.mesh Quality of Life
dc.subject.mesh Societies, Medical
dc.subject.mesh Spain
dc.title SEOM clinical guidelines for anaemia treatment in cancer patients (2020)
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 33768441
dc.relation.publisherversion https://link.springer.com/10.1007/s12094-021-02580-2
dc.identifier.doi 10.1007/s12094-021-02580-2
dc.journal.title Clinical & Translational Oncology
dc.identifier.essn 1699-3055


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta